A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of BION-1301 in Adults with IgA Nephropathy
The medication is taken by injection every 2 weeks for two years.
Biopsy-proven IgAN within past 10 years; stable on ACEi/ARB for at least 12 weeks.
Renal Research Center
James Dylewski, DO
Protocol Number: 23-0695
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers